Share

'Betrayal': 6 reactions to FDA's approval of generic abortion drug

By Samantha Kamman, Christian Post Reporter

6. Health and Human Services Department

The U.S. Department of Health and Human Services building is shown Aug. 16, 2006, in Washington, D.C.
The U.S. Department of Health and Human Services building is shown Aug. 16, 2006, in Washington, D.C. | Mark Wilson/Getty Images

Andrew Nixon, a spokesperson for the Health and Human Services Department, stated that the “FDA has very limited discretion” when it comes to deciding to approve a generic drug, NBC News reported.

“By law, the Secretary of Health and Human Services must approve an application if it demonstrates that the generic drug is identical to the brand-name drug,” Nixon said in a statement.

“Generic applicants are not required to submit independent evidence proving safety and effectiveness,” he added. “HHS is conducting a study of the reported adverse effects of mifepristone to ensure the FDA’s risk mitigation program for the drug is sufficient to protect women from unstated risks.”

Samantha Kamman is a reporter for The Christian Post. She can be reached at: samantha.kamman@christianpost.com. Follow her on Twitter: @Samantha_Kamman

You’ve readarticles in the last 30 days.

Was this article helpful?

Help keep The Christian Post free for everyone.

Our work is made possible by the generosity of supporters like you. Your contributions empower us to continue breaking stories that matter, providing clarity from a biblical worldview, and standing for truth in an era of competing narratives.

By making a recurring donation or a one-time donation of any amount, you’re helping to keep CP’s articles free and accessible for everyone.

We’re sorry to hear that.

Hope you’ll give us another try and check out some other articles. Return to homepage.

Most Popular